Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
jRCT1091220218Completed
Open-label, single-arm trial of esomeprazole in gastroesophageal reflux disease (GERD), sponsored by Chiba University. Primary endpoint: FSSG scale total score. Started Jul 2015; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on jRCT1091220218.